share_log

BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Dachille Douglas A.

SEC announcement ·  Jun 25 17:41
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more